ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 204 filers reported holding ARCUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,511,002 | -45.1% | 195,599 | -37.9% | 0.12% | -36.5% |
| Q2 2023 | $6,394,319 | -39.2% | 314,836 | -45.4% | 0.20% | -38.4% |
| Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
| Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
| Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
| Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
| Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
| Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
| Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |